Surbhi Jain

1.8k citations
54 papers · 1.2k indexed · h-index 23
Topics
Cancer Genomics and Diagnostics (12 papers)Hepatitis B Virus Studies (9 papers)CRISPR and Genetic Engineering (8 papers)
Partner nations
United StatesIndiaTaiwan

In The Last Decade

Surbhi Jain

52 papers receiving 1.1k citations

Peers

Surbhi Jain
Comparison fields: 5 of 111
  • Molecular Biology 542
  • Cancer Research 211
  • Oncology 207
  • Organic Chemistry 195
  • Epidemiology 156
Replace Xiangjun Meng with:
Xiangjun Meng China
Masazumi Eriguchi Japan
Zhiting Cao China
Alessandro Canella Italy
Bo Hu China
Yinli Zhang China
Jenny Ho Australia
Hyung Jun Ahn South Korea
David Rodrı́guez Spain
Surbhi Jain relative to Xiangjun Meng China Xiangjun Meng's profile →
Citations per field
00.5×1.5×1.8×
Xiangjun Meng · 1×
Citations per year

Countries citing papers authored by Surbhi Jain

Since Specialization
Citations

This map shows the geographic impact of Surbhi Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surbhi Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surbhi Jain more than expected).

Fields of papers citing papers by Surbhi Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surbhi Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surbhi Jain. The network helps show where Surbhi Jain may publish in the future.

Co-authorship network of co-authors of Surbhi Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Surbhi Jain. A scholar is included among the top collaborators of Surbhi Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surbhi Jain. Surbhi Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 26
3 69
4 11
5
Maxillary tooth-supported bar overdenture: A case report
1
6 42
7 49
8 4
9 21
10 35
11 10
12 3
13 13
14 22
15 41
16
Poly (3-Hydroxyalkanoates): Biodegradable Plastics
2
17 22
18 22
19 42
20 45

About Surbhi Jain

Surbhi Jain is a scholar working on Cancer Research, Hepatology and Business and International Management, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), Hepatitis B Virus Studies (9 papers) and CRISPR and Genetic Engineering (8 papers). The work is most often cited by research in Hepatology (121 citations), Cancer Research (211 citations) and Business and International Management (20 citations). Surbhi Jain has collaborated with scholars based in United States, India and Taiwan. Frequent co-authors include Ying‐Hsiu Su, Wei Song, Selena Y. Lin, Robert J. Davis, Yaying Ji, Huimin Zhao, Michael V. Autieri, Sheri Kelemen, Timothy M. Block and Robert J. Davis. Their work appears in journals such as Nature Communications, PLoS ONE and The Journal of Physical Chemistry B.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026